BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22252655)

  • 1. Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry.
    Burhenne J; Halama B; Maurer M; Riedel KD; Hohmann N; Mikus G; Haefeli WE
    Anal Bioanal Chem; 2012 Mar; 402(7):2439-50. PubMed ID: 22252655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S; Song N; Li Q; Fan H; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing.
    Witt L; Suzuki Y; Hohmann N; Mikus G; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():207-13. PubMed ID: 27300008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and simultaneous measurement of midazolam, 1'-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry: application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity.
    Xue X; Huang M; Xiao H; Qin X; Huang L; Zhong G; Bi H
    J Pharm Biomed Anal; 2011 Apr; 55(1):187-93. PubMed ID: 21316177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma.
    de Loor H; de Jonge H; Verbeke K; Vanrenterghem Y; Kuypers DR
    Biomed Chromatogr; 2011 Oct; 25(10):1091-8. PubMed ID: 21204116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a method using supported liquid extraction for the simultaneous determination of midazolam and 1'-hydroxy-midazolam in human plasma by liquid chromatography with tandem mass spectrometry detection.
    Svanström C; Hansson GP; Svensson LD; Sennbro CJ
    J Pharm Biomed Anal; 2012 Jan; 58():71-7. PubMed ID: 21993197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput assay for simultaneous quantification of the plasma concentrations of morphine, fentanyl, midazolam and their major metabolites using automated SPE coupled to LC-MS/MS.
    Ghassabian S; Moosavi SM; Valero YG; Shekar K; Fraser JF; Smith MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():126-33. PubMed ID: 22841553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a rapid and sensitive assay for simultaneous quantification of midazolam, 1'-hydroxymidazolam, and 4-hydroxymidazolam by liquid chromatography coupled to tandem mass-spectrometry.
    Dostalek M; Macwan JS; Chitnis SD; Ionita IA; Akhlaghi F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1629-33. PubMed ID: 20434409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
    Link B; Haschke M; Wenk M; Krähenbühl S
    Rapid Commun Mass Spectrom; 2007; 21(9):1531-40. PubMed ID: 17410605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fast and simple method for the simultaneous analysis of midazolam, 1-hydroxymidazolam, 4-hydroxymidazolam and 1-hydroxymidazolam glucuronide in human serum, plasma and urine.
    Wessels AMA; Bolhuis MS; Bult W; Nijsten MWN; Kneyber MCJ; Touw DJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122476. PubMed ID: 33385770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a sensitive assay for analysis of midazolam, free and conjugated 1-hydroxymidazolam and 4-hydroxymidazolam in pediatric plasma: Application to Pediatric Pharmacokinetic Study.
    Moorthy GS; Jogiraju H; Vedar C; Zuppa AF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1067():1-9. PubMed ID: 28978489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry.
    Ahsman MJ; van der Nagel BC; Mathot RA
    Biomed Chromatogr; 2010 Sep; 24(9):969-76. PubMed ID: 20082282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of vorinostat and its main metabolites in plasma and intracellular vorinostat in PBMCs by liquid chromatography coupled to tandem mass spectrometry and its relation to histone deacetylase activity in human blood.
    Liu L; Detering JC; Milde T; Haefeli WE; Witt O; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():212-21. PubMed ID: 24636840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of midazolam and 1'-hydroxymidazolam in human plasma by liquid chromatography with tandem mass spectrometry.
    Li W; Luo S; Smith HT; Tse FL
    Biomed Chromatogr; 2007 Aug; 21(8):841-51. PubMed ID: 17441219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of probe drugs, metabolites, inhibitors and inducer in human plasma by liquid chromatography/tandem mass spectrometry and its application to pharmacokinetic study.
    Hee KH; Yao Z; Lee LS
    J Pharm Biomed Anal; 2014 Jan; 88():584-93. PubMed ID: 24211708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly sensitive LC-MS-MS assay for analysis of midazolam and its major metabolite in human plasma: applications to drug metabolism.
    Jabor VA; Coelho EB; Dos Santos NA; Bonato PS; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):27-32. PubMed ID: 15993663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity.
    Shimizu M; Uno T; Tamura HO; Kanazawa H; Murakami I; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):275-81. PubMed ID: 17085083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
    Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
    Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a liquid chromatography coupled to tandem mass spectrometry method for the simultaneous quantification of five analgesics and sedatives, and six of their active metabolites in human plasma: Application to a clinical study on the determination of neurological death in the intensive care unit.
    Jutras M; Williamson D; Chassé M; Leclair G
    J Pharm Biomed Anal; 2020 Oct; 190():113521. PubMed ID: 32861167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.
    Oh KS; Park SJ; Shinde DD; Shin JG; Kim DH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():56-64. PubMed ID: 22483397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.